Arvinas, Inc.

Ownership Transactions Reported by 21 Insiders

Symbol
ARVN on Nasdaq
Location
395 Winchester Ave, 5 Science Park, New Haven, CT

Insiders trading volume in the past year

Arvinas, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Timothy M. Shannon Director $27.9M Jun 16, 2022
John Houston President and CEO, Director $22.9M -$524K -2.24% Feb 24, 2025
Sean A. Cassidy Chief Financial Officer $8.56M Feb 23, 2024
Andrew Saik Chief Financial Officer $4.26M Feb 13, 2025
Ronald Peck Chief Medical Officer $4.11M Feb 23, 2024
Ian Taylor President, R&D $3.14M -$151K -4.59% Feb 24, 2025
Liam Ratcliffe Director $3.13M Jun 16, 2022
Randy Teel Int. Chief Financial Officer $3.11M May 21, 2024
Angela M. Cacace Chief Scientific Officer $2.81M -$70.2K -2.44% Feb 24, 2025
Edward Moore Kennedy Jr. Director $2.63M May 29, 2024
Noah Berkowitz Chief Medical Officer $2.29M -$74.4K -3.14% Mar 18, 2025
Briggs Morrison Director $1.56M May 29, 2024
Bradley Margus Director $1.15M Jun 16, 2022
Sunil Agarwal Director $810K May 29, 2024
Leslie V. Norwalk Director $617K May 29, 2024
Everett Cunningham Director $617K May 29, 2024
Laurie Smaldone Director $617K May 29, 2024
Linda Bain Director $617K May 29, 2024
John D. Young Director $617K May 29, 2024
David K. Loomis Chief Accounting Officer $575K -$26.7K -4.44% Feb 24, 2025
Wendy L. Dixon Director $351K Jun 15, 2023

Recent Insider Transactions by Companies or Individuals for Arvinas, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.